India's insurance sector has traversed a remarkable journey since privatisation in 2000 — from a largely state-controlled, paper-driven industry to a dynamic, technology-enabled ecosystem. Yet the core principles of underwriting discipline, risk integrity and customer-centricity remain as vital today as they were at inception.
This edition brings together voices from across the industry — practitioners who have shaped underwriting philosophy, clinical audit frameworks and regulatory compliance — to share unfiltered perspectives on where we stand and where we must go. From lipid fraud in medical underwriting to fabricated surgical claims, from IRDAI's evolving stance on claim rejections to AI's role in risk management — this issue covers it all.
Four case studies revealing the intersection of clinical judgement, underwriting scrutiny and audit intelligence. Each article presents a real-world scenario with key takeaways for practitioners.
Product: Pure Term Plan | Sum Assured: ₹1 Crore | Life Assured: Age 54, Business Profile
A 54-year-old male applicant for a ₹1 Crore pure term plan was issued at standard rate — despite significant red flags that should have triggered a decline.
| Area | Observation | Action Taken | Correct Action |
|---|---|---|---|
| Photo Verification | LA appears significantly older than 54 in photo | Not flagged | Request alternate age proof |
| Age Discrepancy | Son (nominee) is 40 — only 14-year gap with LA | Not flagged | Investigate; highly suspicious |
| Financial Underwriting | P&L net profit ≠ income declared in ITRs (AY24/25: ₹4.5L, AY25/26: ₹6L) | Not verified | Reconcile financials; seek explanation |
| Final Decision | Issued at standard, full cover | Issued | DECLINE |
Applicant: 45-year-old male, non-smoker | BMI: 27 | No diabetes or hypertension
Initial labs showed elevated Total Cholesterol (260 mg/dL), high LDL-C (170 mg/dL), critically low HDL-C (19 mg/dL) and borderline high Triglycerides (220 mg/dL). Case was postponed for 6 months or until lipids normalised.
One month later the applicant reapplied with a dramatically improved profile: Total Cholesterol 190, LDL-C 121, HDL-C 48, Triglycerides 164. He stated he had started Statin-Fenofibrate combination therapy.
Patient: 24-year-old male | Admission: 3.1.24–6.1.24 | Procedure: ORIF of left radius shaft fracture
A patient admitted with a displaced left radius shaft fracture underwent ORIF. However, operative records — including anaesthetist notes, OT report and nursing notes — consistently stated the procedure was performed under spinal anaesthesia.
Spinal anaesthesia blocks nerve transmission below the injection level (typically T4–L5) and is conventionally used for lower abdomen, pelvis and lower limb surgeries. Its use for isolated forearm surgery is anatomically and clinically implausible — it would not provide anaesthesia to the upper limb.
Chartered Insurer and former MD & CEO of Pramerica Life Insurance, Ms. Kalpana Sampat shares her perspective on underwriting evolution, fraud control, AI governance and regulatory compliance across 40+ years in the industry.
"Over the last 25 years, underwriting has evolved from a heavily paper-driven administrative process into a far more structured, technology-enabled and governance-oriented discipline. PAN validation, Aadhaar authentication and government database integrations have strengthened the sanctity of customer information."
"One of the strongest safeguards against fraud continues to be a well-trained and ethically aligned sales force. The 'maker-checker' culture remains highly relevant — the sales function as the maker, underwriting and risk teams as the checker."
Strengthening Insurance Contracts Through Compliance, Clinical Reasoning and Judicial Awareness. Health insurance contracts in India are increasingly being interpreted through a wider lens — medical necessity, policyholder fairness and regulatory compliance are no longer separate considerations.
The Court held that an insurer cannot reject a genuine reimbursement claim merely because of delayed filing. If the hospitalisation, treatment, expenses and medical records are genuine, delay alone may not be sufficient ground for repudiation. Insurers must demonstrate that the delay caused material prejudice to their ability to verify the claim.
Recent regulatory directions focus on: continuity of coverage, renewal rights, portability, moratorium periods, faster claim processing, wider product accessibility and clearer policyholder communication. Compliance now extends to how exclusions are applied, how medical necessity is evaluated and how decisions are documented.
As regulatory scrutiny and judicial intervention increase, insurers must strengthen the medical intelligence layer within claims management. Protocol-based reviews, evidence-backed claim notes and clinically reasoned decisions will help reduce disputes, improve compliance and build greater trust in health insurance contracts. The strongest claims process is one where medical experts, legal teams and claims teams work together — not in silos.
Numbers tell a story that anecdotes cannot. This edition's data snapshot tracks fraud incidence rates, early claim ratios, digital adoption metrics and regulatory enforcement trends across India's life and health insurance segment.
Continuous upskilling is the bedrock of a resilient insurance workforce. InCHES Academy brings structured learning pathways for underwriting, claims, compliance and leadership — aligned with CII, IRDAI and international standards.
Every issue we address a real question submitted by practitioners from the field — anonymised and answered by our expert panel. This is where theory meets reality.
Read the full answer ↗